Time & Sales
Price Size Time
0.24 1000 15:59:43
0.24 500 15:59:33
0.24 500 15:59:33
0.24 5000 15:55:41
0.24 5000 15:55:41
0.24 6400 15:54:28
0.24 10000 15:54:25
0.24 10000 15:52:54
0.24 10000 15:52:51
0.24 600 15:52:15
0.25 2000 15:52:05
0.25 1000 15:50:33
0.24 10000 15:50:21
0.24 10000 15:50:17
0.25 3000 15:48:26
0.25 3000 15:47:04
0.24 2000 15:46:57
0.25 8000 15:45:57
0.24 20400 15:44:37
0.24 8000 15:38:57
0.24 10000 15:38:46
0.24 600 15:34:15
0.24 10000 15:30:53
0.24 10000 15:30:17
0.24 37400 15:24:57
0.24 5000 15:24:41
0.24 10600 15:24:03
0.23 17000 15:23:34
0.23 16000 15:23:32
0.24 18500 15:22:00
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To be held on June 30, 2005
May __, 2005
NOTICE IS HEREBY GIVEN that the 2005 Annual Meeting of Stockholders of Calypte Biomedical Corporation (the "Company") will be held at the Four Points Sheraton Hotel located at 5115 Hopyard Road, Pleasanton, California, 94588, on Thursday, June 30, 2005, at 10:00 a.m. local time, for the following purposes:
1. To elect five directors of the Company to hold office until the next Annual Meeting of Stockholders or until their successors are elected.
2. To vote on a proposal to approve the issuance of shares of common stock in excess of 19.99% of the outstanding common stock and price adjustments in connection with our April 2005 issuance of Notes and Warrants;
3. To vote on a proposal to approve the issuance of additional shares of common stock and warrant shares and adjustment of the warrant exercise price in connection with amended securities granted to 3 the investors in our May and July 2004 placements;
4. To vote on a proposal to adopt the Company's 2005 Director Incentive Plan (Appendix A hereto) and to authorize 18,000,000 shares of the Company's Common Stock for issuance thereunder;
5. To vote on a proposal to amend the Company's 2004 Incentive Plan (Appendix B hereto) to increase by 17,000,0000 shares the number of shares of the Company's Common Stock authorized for issuance thereunder; to permit awards to employees, consultants and others who provide services to affiliates of the Company thereunder; and to increase to 20,000,000 shares the number of shares of Common Stock available for delivery as restricted stock and restricted stock units thereunder;
6. To ratify the appointment by the Audit Committee and the Board of Directors of Odenberg Ullakko Muranishi & Co. LLP as the independent registered public accounting firm to audit the Company's 6 financial statements for the fiscal year ending December 31, 2005; and
7. To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
Stockholders of record on May 9, 2005 will be eligible to vote at this meeting. Only stockholders of record at the close of business on that date will be entitled to notice of and to vote at the meeting. To ensure your representation at the meeting, you are urged to mark, sign, date and return the enclosed proxy as promptly as possible in the envelope provided or to vote via the internet or by telephone. If you attend the meeting, you may vote in person even if you return a proxy.
By order of the Board of Directors,
/s/ J. Richard George
J. Richard George
President and Chief Executive Officer
geht mal schön hin und hört mal nach, über wieviele shares zur weitere zulassung abgestimmt wird...
Text zur Anzeige gekürzt. Gesamten Beitrag anzeigen »